TransGenex Nanobiotech Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

TransGenex Nanobiotech General Information

Description

Developer of nano-scale technologies intended for diagnostic and therapeutic agents against cancers and other inflammatory diseases. The company develops a fiber-inspired scaffold technology platform that enables the development of multicellular tumor spheroids that fully resemble tumors in vivo, providing cancer patients with improved drug discovery and development, as well as better prediction of the clinical efficacy of drugs for personalized cancer treatment.

Contact Information

Website
www.transgenex.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Primary Office
  • 13719 North Nebraska Avenue
  • Tampa, FL 33613
  • United States
+1 (813) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TransGenex Nanobiotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Generating Revenue
4. Accelerator/Incubator 18-Jun-2015 Completed Generating Revenue
3. Grant 01-Jan-2015 00.000 Completed Generating Revenue
2. Grant 01-Jan-2009 $427K Completed Startup
1. Grant 01-Jan-2008 $1.03M Completed Startup
To view TransGenex Nanobiotech’s complete valuation and funding history, request access »

TransGenex Nanobiotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of nano-scale technologies intended for diagnostic and therapeutic agents against cancers and other inflammato
Biotechnology
Tampa, FL
6 As of 2023
000000 - 000

000000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conse
0000000000000
Schlieren, Switzerland
00 As of 0000
000.00
0000 0000-00-00
0000000000 0 000.00

000000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000000000000
Vancouver, Canada
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TransGenex Nanobiotech Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSphero Venture Capital-Backed Schlieren, Switzerland 00 000.00 0000000000 0 000.00
000000 0000000000 Venture Capital-Backed Vancouver, Canada 00 000.00 0000000000 0 000.00
0000000 000000000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
00 000000 Corporate Backed or Acquired Bridgewater, NJ 0 000000&0
To view TransGenex Nanobiotech’s complete competitors history, request access »

TransGenex Nanobiotech Patents

  • 33

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 6

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

TransGenex Nanobiotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200323949-A1 Molecular engineering of a novel ternary complex of actinomycin d for cancer stem cells treatment Inactive 10-Apr-2019 000000000
US-20220185767-A1 Novel ternary molecular complex of tamibarotene for cancer stem cells treatment Pending 02-Apr-2019 000000000
CA-3091127-A1 Novel crystalline forms of tamibarotene for treatment of cancer Pending 13-Feb-2018 0000000000
EP-3752159-A2 Novel crystalline forms of tamibarotene for treatment of cancer Inactive 13-Feb-2018 0000000000
US-20210002209-A1 Novel crystalline forms of tamibarotene for treatment of cancer Pending 13-Feb-2018 C07D213/78
To view TransGenex Nanobiotech’s complete patent history, request access »

TransGenex Nanobiotech Executive Team (6)

Name Title Board Seat Contact Info
Chandresh Saraiya MD President & Vice President of Medical affairs
Bernard Skerkowski Vice President of Finance & President
Mazen Hanna Ph.D President & Board Member
Shyam Mohapatra Ph.D Co-Founder & Chairman
You’re viewing 4 of 6 executive team members. Get the full list »

TransGenex Nanobiotech Board Members (3)

Name Representing Role Since
Mazen Hanna Ph.D TransGenex Nanobiotech President & Board Member 000 0000
Shyam Mohapatra Ph.D TransGenex Nanobiotech Co-Founder & Chairman 000 0000
Subhra Mohapatra Ph.D TransGenex Nanobiotech Co-Founder & Advisory Board Member 000 0000
To view TransGenex Nanobiotech’s complete board members history, request access »

TransGenex Nanobiotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TransGenex Nanobiotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Institute for Commercialization of Florida Technology Not-For-Profit Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view TransGenex Nanobiotech’s complete investors history, request access »

Ready to get started?

Request a free trial